A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dexfenfluramine
Osimertinib
Safinamide may decrease the excretion rate of Osimertinib which could result in a higher serum level.
Dexfenfluramine
Tenofovir alafenamide
Safinamide may decrease the excretion rate of Tenofovir alafenamide which could result in a higher serum level.
Dexfenfluramine
Ombitasvir
Safinamide may decrease the excretion rate of Ombitasvir which could result in a higher serum level.
Dexfenfluramine
Lenvatinib
Safinamide may decrease the excretion rate of Lenvatinib which could result in a higher serum level.
Dexfenfluramine
Palbociclib
Safinamide may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Dexfenfluramine
Sofosbuvir
Safinamide may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dexfenfluramine
Dolutegravir
Safinamide may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Dexfenfluramine
Afatinib
Safinamide may decrease the excretion rate of Afatinib which could result in a higher serum level.
Dexfenfluramine
Dabrafenib
Safinamide may decrease the excretion rate of Dabrafenib which could result in a higher serum level.
Dexfenfluramine
Vemurafenib
Safinamide may decrease the excretion rate of Vemurafenib which could result in a higher serum level.
Dexfenfluramine
Teriflunomide
Safinamide may decrease the excretion rate of Teriflunomide which could result in a higher serum level.
Dexfenfluramine
Pitavastatin
Safinamide may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Dexfenfluramine
Deutetrabenazine
The risk or severity of adverse effects can be increased when Safinamide is combined with Deutetrabenazine.
Dexfenfluramine
Pitolisant
The serum concentration of Safinamide can be decreased when it is combined with Pitolisant.
Dexfenfluramine
Aripiprazole lauroxil
The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Aripiprazole lauroxil.
Dexfenfluramine
Aripiprazole
The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Aripiprazole.
Dexfenfluramine
Levacetylmethadol
The risk or severity of adverse effects can be increased when Safinamide is combined with Levacetylmethadol.
Dexfenfluramine
Carfentanil, C-11
The risk or severity of adverse effects can be increased when Carfentanil, C-11 is combined with Safinamide.
Dexfenfluramine
Tilidine
The risk or severity of adverse effects can be increased when Tilidine is combined with Safinamide.
Dexfenfluramine
Phenazocine
The risk or severity of adverse effects can be increased when Phenazocine is combined with Safinamide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3